Source link : https://health365.info/diabetes-medication-connected-to-raised-chance-of-uncommon-optic-nerve-harm/
New analysis hyperlinks two extensively used diabetes medication, semaglutide or tirzepatide, to a unprecedented however probably vision-threatening eye situation, elevating questions on drug-specific dangers and the desire for nearer tracking.
Learn about: Semaglutide or Tirzepatide and Optic Nerve and Visible Pathway Problems in Sort 2 Diabetes. Symbol credit score: Vince Scherer/Shutterstock.com
A learn about revealed in JAMA Community Open reported that remedy with antidiabetic medications semaglutide and tirzepatide will increase the chance of optic neuropathy and different optic nerve problems in sufferers with kind 2 diabetes.
Background
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are a bunch of medicines extensively used to regard diabetic or overweight people. Those medicines have top doable to cut back diabetes-related headaches, together with cardiovascular and nephrological problems.
Semaglutide and tirzepatide are second-generation GLP-1RA medicines licensed via the U.S. Meals and Drug Management (FDA) for treating diabetes and weight problems. On the other hand, those medicines are related to adversarial unwanted effects, together with gastrointestinal problems, thyroid C-cell tumors, and pancreatitis.
Some fresh research have connected semaglutide and tirzepatide with higher chance of nonarteritic anterior ischemic optic neuropathy. On the other hand, the reported associations are inconclusive, and it in large part stays unknown whether or…
—-
Author : admin
Publish date : 2025-08-14 14:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8